awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36673777-32E9A7BB-6848-4676-9730-A86D83C8BF1B
Q36673777-32E9A7BB-6848-4676-9730-A86D83C8BF1B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36673777-32E9A7BB-6848-4676-9730-A86D83C8BF1B
Additive antitumour effect of the epidermal growth factor receptor tyrosine kinase inhibitor gefitinib (Iressa, ZD1839) and the antioestrogen fulvestrant (Faslodex, ICI 182,780) in breast cancer cells
P2860
Q36673777-32E9A7BB-6848-4676-9730-A86D83C8BF1B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36673777-32E9A7BB-6848-4676-9730-A86D83C8BF1B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
adc4f5d4795f92b6e6adaa1db1d76b0ca096bceb
P2860
Overexpression of c-erbB2 is an independent marker of resistance to endocrine therapy in advanced breast cancer.